Supplemental value of diffusion‐weighted whole‐body imaging with background body signal suppression (DWIBS) technique to whole‐body magnetic resonance imaging in detection of bone metastases from thyroid cancer

@article{Sakurai2013SupplementalVO,
  title={Supplemental value of diffusion‐weighted whole‐body imaging with background body signal suppression (DWIBS) technique to whole‐body magnetic resonance imaging in detection of bone metastases from thyroid cancer},
  author={Yusuke Sakurai and H. Kawai and Shingo Iwano and Shinji Ito and Hiroshi Ogawa and Shinji Naganawa},
  journal={Journal of Medical Imaging and Radiation Oncology},
  year={2013},
  volume={57}
}
We compared the efficacy of whole‐body MRI (WBMRI) with and without diffusion‐weighted whole‐body imaging with background body signal suppression (DWIBS) using a 3.0‐T MR scanner to [18F] fluoro‐2‐D‐glucose positron emission tomography with CT (integrated FDG‐PET/CT) for the detection of bone metastases in patients with differentiated thyroid carcinoma (DTC). 
View on Wiley
ncbi.nlm.nih.gov
22 Citations
Highly Influential Citations
5
Background Citations
6
Methods Citations
2
Results Citations
3

22 Citations

Citation Type

Citation Type

Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
TLDR
In bone metastases of thyroid tumors and melanoma, the WB-MRI-DWI shows a higher sensitivity when compared to 18F-FDG PET/CT, and this method seems to play an important role in the diagnosis of bone solid tumor metastases.
Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma
TLDR
The specificity, overall accuracy, and PPV of whole-body DWIBS are significantly lower than those of 18F-FDG PET/CT for detecting lymph node and bone metastases in pediatric patients with neuroblastoma because of a high incidence of false-positive findings particularly for detecting bone metastasis.
Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus 18F-FDG PET/CT for Detection of Bone Metastases.
TLDR
WB DWIBS coupled with ADC analysis at 3 T is effective for detecting bone metastases and the sensitivity, specificity, overall accuracy, positive predictive value, and negative predictive value of both modalities were calculated.
Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer.
TLDR
DWIBS/T2 enabled the diagnosis of pancreatic cancer in cases where it was not detected with US, T1WI or T2WI, and was the same as that of abdominal US and CECT in detecting primary and metastatic liver cancer.
Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer
TLDR
WB-DWI is reliable in detecting tumour recurrence and metastasis of colorectal cancer and offers the same diagnostic performance as 18F-PET/CT without ionizing radiation, and the quantitative value of ADC provides extra information to determine cancer metastasis.
Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Diffusion-Weighted MR Imaging in Oncology
TLDR
The use of DW-MRI for the evaluation of treatment response, including its emerging role as a predictive and/or prognostic biomarker, and the use of more sophisticated data analysis to derive quantitative parameters are discussed.
Whole-Body MR Imaging: Musculoskeletal Applications.
TLDR
The currently established and potential indications for whole-body MR imaging in oncology and rheumatology are reviewed, discussing the diagnostic performance, advantages, and drawbacks of the technique, and its potential roles in comparison to other imaging modalities.
Whole-Body MR Imaging: The Novel, "Intrinsically Hybrid," Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond.
Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults
TLDR
Both 2-[18F]FDG-PET and DW-MRI can miss bone marrow metastases and the combination of both imaging techniques detected significantly more lesions than either technique alone, although the “blind spot” of each modality is different.
...
1
2
3
...

References

SHOWING 1-10 OF 33 REFERENCES
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology
TLDR
The recently introduced concept of “diffusion-weighted whole-body imaging with background body signal suppression” (DWIBS) now allows acquisition of volumetric diffusion- Weighted images of the entire body.
Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
TLDR
WB-MRI that included DWI was useful for detecting bone metastasis and compared it with that of skeletal scintigraphy (SS), which was superior to those of session 1 (sensitivity: 88%; PPV: 95%) and those of SS (s sensitivity: 96%;PPV: 94%).
Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla
TLDR
The purpose was to provide a diffusion-weighted whole-body magnetic resonance (MR) imaging sequence with background body signal suppression (DWIBS) at 3.0 Tesla, and a good correlation was found between the metastases as depicted by DWIBS and those as visualized by FDG-PET.
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging
TLDR
DWI seems to be a sensitive but unspecific modality for the detection of locoregional or metastatic BC disease and DWI alone may not be recommended as a whole-body staging alternative to FDG PET(/CT).
Diffusion‐weighted whole‐body MRI with background body signal suppression: Technical improvements at 3.0 T
TLDR
To improve image quality of diffusion‐weighted body magnetic resonance imaging (MRI) with background body signal suppression (DWIBS) at 3.0 T, a diffusion-weighted magnetic resonance machine is used.
Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.
TLDR
Three-dimensional DWIBS can be obtained with this technique, which may allow us to screen for malignancies in the whole body through diffusion weighted whole body imaging with background body signal suppression.
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT
TLDR
WB-MRI and FDG-PET-CT are robust imaging modalities for a systemic screening for metastatic bone disease and PAT allows WB-MRI bone marrow screening at high spatial resolution and with a diagnostic accuracy superior to PET-CT.
Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT.
Turbo STIR magnetic resonance imaging as a whole‐body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience
TLDR
Preliminary clinical experience suggests that turbo STIR whole‐body MRI may represent a convenient and cost‐effective method of total body screening for metastases in patients with breast carcinoma.
Feasibility of whole body diffusion weighted imaging in detecting bone metastasis on 3.0T MR scanner.
...
1
2
3
4
...